See also this year's filing and all EDGAR filings for this company.
PDF Report 0001815903_2023_Petros_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001815903, Petros Pharmaceuticals Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 14,667,905 |
1 | IntangibleAssetsNetIncludingGoodwill | 12,244,484 |
2 | PropertyPlantAndEquipmentNet | 39,177 |
3 | remainder_Assets | 5,469,648 |
4 | LiabilitiesCurrent | 7,067,976 |
5 | LiabilitiesNoncurrent | 262,678 |
6 | remainder_Liabilities | 8,388,093 |
7 | CostOfGoodsAndServicesSold | 2,289,418 |
8 | SellingGeneralAndAdministrativeExpense | 12,209,162 |
9 | ResearchAndDevelopmentExpense | 1,740,280 |
10 | remainder_Expenses | 10,264,961 |
11 | remainder_Revenues | 5,992,054 |
12 | remainder_NetIncome | 474,194 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 32,421,214 |
1 | Liabilities | 15,718,747 |
2 | Expenses | 26,503,821 |
3 | Revenues | 5,992,054 |
4 | StockholdersEquity | 16,702,467 |
5 | NetIncome | -20,037,573 |
6 | ComprehensiveNetIncome | -20,037,573 |
7 | BaseVar | 40,555,015 |
8 | EconomicCapitalRatio | 0.361 |